15th Annual Sickle Cell Disease Research and Educational Symposium And 44th National Sickle Cell Disease Scientific Meeting

Thursday, May 27, 2021

Welcome + The State of Sickle Cell Disease

Care for Patients with Sickle Cell Disease in the COVID-19 Era

Keynote Address for the 4th Annual Sickle Cell Disease Access to Care Summit

Panel 1 The Economic & Financial Impact of Sickle Cell Disease

Panel 2 Physical and Financial Access to COVID-19 Vaccination

The Patient Symposium A Tale of Two Pandemics

Access to Excellent Care for Sickle Cell Patients (ACCEL) Grant Awardee Presentations

Friday, May 28, 2021

2021 Scientific Chair Welcome

Genomics Educational Session

End Organ Dysfunction Educational Session

The Global Status of Sickle Cell Disease Symposium

COVID-19 and Sickle Cell Disease Clinical Implications

Keynote Presentation – COVID-19 Lessons Learned

Saturday, May 29, 2021

Federal Agency Updates

Gene Therapy and Bone Marrow Transplant Educational Session

Investigational New Drug, Device and Therapeutics Symposium

Scientific Keynote Presentation

Top Abstracts Oral Presentations

Sunday, May 30, 2021

Surgery and Sickle Cell Disease Educational Session

Abstract Breakout Session I Clinical Research Oral Presentations

Abstract Breakout Session II Basic Science Oral Presentations

Abstract Breakout Session III Health Services & Psychosocial Oral Presentations

Fixing the Continuity Problem A Different Approach to Adherence for Transitioning Sickle Cell Disease Patients Educational Session

Community Access to Oxbryta and Adakveo

Randomized Controlled Trial of Fixed Moderate-Dose versus Fixed Low-Dose Hydroxyurea for SECONDARY STROKE PREVENTION in Children

Voxelotor treatment and laboratory tests what you need to know

An Overview of Sickle Cell Disease Therapeutics

An Overview of Sickle Cell Disease Therapeutics

You are unauthorized to view this page.